南美洲和中美洲护理点分子诊断市场预测至 2028 年 - COVID-19 影响和按产品和服务(检测和试剂盒、仪器、服务和软件)、技术(PCR、等温核酸扩增技术( INAAT)和其他技术)、应用(传染病、肿瘤学、血液学、产前检测、内分泌学和其他应用)、最终用户(医院和诊所、诊断实验室、研究和学术机构等)

TIPRE00026194 | Pages: 167 | Medical Device | Dec 2021 | Type: Regional | Status: Published

市场介绍

即时分子诊断包括便携式设备以及检测和分析;用于检测和诊断人类样本中疾病的试剂盒,例如咽拭子、血液、血清和粪便。分子诊断正在从集中实验室转向分散的护理点分子测试。由于其简单、方便、周转时间短以及改善患者治疗效果的潜力,POCT 正在迅速获得关注。

此外,对消耗特定病毒检测方法的需求不断增长及时控制感染的时间预计将在预测期内促进市场增长。

巴西报告的 COVID-19 病例数是南美洲和中美洲最多的,其次是巴西阿根廷、秘鲁、智利和厄瓜多尔等国。该地区各国政府已采取多项行动来保护其公民并遏制疾病传播。 COVID-19 的持续传播正在推动即时诊断市场的增长。此外,预计对 COVID-19 现代化诊断解决方案的需求激增也将对南美洲和中美洲即时分子诊断市场的增长产生积极影响。

< span> 

市场概况与动态

南部和南部中美洲即时分子诊断市场预计将从 2021 年的 1.234 亿美元增至 2028 年的 2.822 亿美元。预计从 2021 年到 2028 年,该市场将以 12.5% 的复合年增长率增长。互联消费电子产品的兴起改变了整个经济领域,包括医疗保健。患者和消费者正在调整他们与 POC 医疗产品和服务的互动。移动设备的普及带来的服务。此外,随着联网设备的兴起,消费者正在改变他们管理和控制健康的方式。因此,制造商正在开发易于使用、方便且价格实惠的非实验室环境 POC 分子诊断设备,以满足日益增长的消费者需求。由于快速发展的技术格局以及智能手机和联网设备的普及率不断上升,预计 POC 分子诊断和监测设备未来将在低收入和中等收入经济体的住宅环境中变得司空见惯。

 

主要细分市场

在产品和服务方面服务方面,检测和试剂盒部分占据了南美的最大份额。 2020年中美洲床旁分子诊断市场。就技术而言,PCR细分市场占据南美洲最大份额。 2020年中美洲护理点分子诊断市场。就应用而言,传染病细分市场占南美地区最大份额。 2020年中美洲护理点分子诊断市场。就最终用户而言,诊断实验室领域占据了南美和中美洲的最大份额。 2020 年中美洲护理点分子诊断市场。

 

主要来源和上市公司

准备这份关于南美和南美地区护理点分子诊断市场报告时提到的一些主要的一手和二手资料来源。中美洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 BioMérieux SA、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Enzo Biochem, Inc.、Abbott、Meridian BioScience, Inc.、Biocartis、Quidel Corporation 和 Bio-Rad Laboratories, Inc. .

 

购买原因报告

  • 了解南方和南方中美洲即时分子诊断市场格局并确定可能保证丰厚回报的细分市场
  • 了解不断变化的市场格局并在竞争中保持领先地位
  • 有效规划南部和南部地区的并购和合作交易。中美洲护理点分子诊断市场,通过识别最有前景的可能销售细分市场
  • 通过对各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策
  • 获取南、北地区市场收入预测。 2021 年至 2028 年不同细分市场的中美洲护理点分子诊断市场

 

 

南部和南部中美洲护理点分子诊断市场细分

 

< span>按 产品和产品服务

  • 检测和试剂盒
  • 仪器
  • 服务和软件

 

按技术

  • PCR
  • 等温核酸扩增技术(INAAT)
  • 其他技术

 

作者应用

  • 传染病
  • 肿瘤学
  • 血液学
  • 产前检测
  • 内分泌学
  • 其他应用

 

作者最终用户

  • 医院和诊所
  • 诊断实验室
  • 研究及学术机构
  • 其他

按国家/地区

  • 南部和南部中美洲
    • 巴西
    • 阿根廷
    • 南部及其他地区中美洲

提及的公司

  • bioMérieux SA
  • F.霍夫曼-拉罗氏有限公司
  • 丹纳赫公司
  • Enzo Biochem, Inc.
  • 雅培
  • Meridian BioScience, Inc.
  • Biocartis
  • Quidel 公司
  • Bio-Rad Laboratories, Inc.
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2        South & Central America Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3        South & Central America Point-of-Care Molecular Diagnostics Market – By Application

1.3.4        South & Central America Point-of-Care Molecular Diagnostics Market – By End User

1.3.5        South & Central America Point-of-Care Molecular Diagnostics Market– By Geography

2.           South & Central America Point-of-Care Molecular Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America – PEST Analysis

4.3         Experts Opinion

5.           Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2        Rising Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        Pricing Pressures owing to Reimbursement Cuts

5.3         Market Opportunities

5.3.1        Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4         Future Trends

5.4.1        Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5         Impact Analysis

6.           Point-of-Care Molecular Diagnostics Market– South & Central America Analysis

6.1         South & Central America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7.           Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1         Overview

7.2         Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3         Assays and Kits

7.3.1        Overview

7.3.2        Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Services and Software

7.5.1        Overview

7.5.2        Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1         Overview

8.2         Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3         PCR

8.3.1        Overview

8.3.2        PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1        Overview

8.4.2        Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1         Overview

9.2         Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3         Infectious Disease

9.3.1        Overview

9.3.2        Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Oncology

9.4.1        Overview

9.4.2        Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Hematology

9.5.1        Overview

9.5.2        Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Prenatal Testing

9.6.1        Overview

9.6.2        Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Endocrinology

9.7.1        Overview

9.7.2        Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1      Overview

10.2      Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Diagnostic Laboratories

10.4.1     Overview

10.4.2     Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Research and Academic Institutes

10.5.1     Overview

10.5.2     Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        South & Central America Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1      South and Central America: Point-of-Care Molecular Diagnostics Market

11.1.1     Overview

11.1.2     South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3     South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

11.1.4     South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

11.1.5     South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

11.1.6     South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

11.1.7     South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

11.1.7.1       Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1       Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2       Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.1.3       Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.1.4       Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.1.5       Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.2       Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1       Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2       Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.2.3       Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.2.4       Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.2.5       Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.3       Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1       Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2       Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.3.3       Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.3.4       Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.3.5       Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

12.        Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1      South & Central America: Impact Assessment of COVID-19 Pandemic

13.        Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3      Organic Growth Strategies

13.3.1     Overview

13.4      Inorganic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      F. Hoffmann-La Roche Ltd.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      bioMérieux SA

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Abbott

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      MERIDIAN BIOSCIENCE, INC.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Enzo Biochem Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Biocartis

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Quidel Corporation

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Danaher

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      BIO-RAD LABORATORIES INC.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 2.             South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 3.             South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 4.             South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 7.             Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 9.             Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 10.          Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 18.          Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 19.          Glossary of Terms, Point-of-Care Molecular Diagnostics Market

 


LIST OF FIGURES

Figure 1.           Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2.           South & Central America Point-of-Care Molecular Diagnostics Market Overview

Figure 3.           Assays and Kits Segment Held the Largest Share by Product & services in South & Central America Point-of-Care Molecular Diagnostics Market

Figure 4.           Brazil to Show Significant Growth During Forecast Period

Figure 5.           South & Central America Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6.           South & Central America PEST Analysis

Figure 7.           South & Central America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8.           Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9.           Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13.        PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17.        Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24.        Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

Figure 29.        South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 30.        South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

Figure 31.        Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South & Central America

Figure 35.        Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

  1. bioMérieux SA
  2. F. Hoffmann-La Roche Ltd.
  3. Danaher Corporation
  4. Enzo Biochem, Inc.
  5. Abbott
  6. Meridian BioScience, Inc.
  7. Biocartis
  8. Quidel Corporation
  9. Bio-Rad Laboratories, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Point-of-Care molecular diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000